Vera Therapeutics
Price & Volume
Stats
See more52W Range | $19.06-$56.05 |
Market Cap | $3B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$5.54 |
News
See moreYahoo Finance • 6 days ago
Vera Therapeutics Wins FDA Accelerated Approval For TRUTAKNA In Primary IgA Nephropathy
Yahoo Finance • 7 days ago
Vera gains after FDA nod for kidney disease therapy
Yahoo Finance • 7 days ago
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy
Yahoo Finance • 8 days ago
Scilex, Vera Therapeutics rise premarket; Strategy gains
About
CEO | Dr. Marshall W. Fordyce M.D. |
Address | 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 339 |